GILEAD SCIENCES INC 4
4 · GILEAD SCIENCES INC · Filed Aug 1, 2013
Insider Transaction Report
Form 4
MADIGAN JOHN W
Director
Transactions
- Exercise/Conversion
Non-Qualified Stock Options (right to buy)
2013-07-30−105,000→ 0 totalExercise: $14.34Exp: 2016-05-10→ Common Stock (105,000 underlying) - Exercise/Conversion
Common Stock
2013-07-30$12.99/sh+120,000$1,559,400→ 179,580 total - Sale
Common Stock
2013-07-30$61.97/sh−249,000$15,430,655→ 35,580 total - Exercise/Conversion
Common Stock
2013-07-30$14.34/sh+105,000$1,505,438→ 284,580 total - Exercise/Conversion
Non-Qualified Stock Options (right to buy)
2013-07-30−120,000→ 0 totalExercise: $12.99Exp: 2015-12-12→ Common Stock (120,000 underlying) - Exercise/Conversion
Non-Qualified Stock Options (right to buy)
2013-07-30−24,000→ 0 totalExercise: $14.34Exp: 2016-01-26→ Common Stock (24,000 underlying) - Exercise/Conversion
Common Stock
2013-07-30$14.34/sh+24,000$344,160→ 59,580 total
Footnotes (3)
- [F1]Options vest annually over a period of two years from the grant date.
- [F2]Options are 100% vested on the date of grant.
- [F3]Sale prices reported for the transactions reported here range from $61.97 to $62.01. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.